Sexual Activity and Function in Patients With Gynecological Malignancies After Completed Treatment
Standard
Sexual Activity and Function in Patients With Gynecological Malignancies After Completed Treatment. / Grimm, Donata; Hasenburg, Annette; zu Eulenburg, Christine; Steinsiek, Lisa; Mayer, Sebastian; Eltrop, Stephanie; Prieske, Katharina; Trillsch, Fabian; Mahner, Sven; Woelber, Linn.
in: INT J GYNECOL CANCER, Jahrgang 25, Nr. 6, 07.2015, S. 1134-41.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Sexual Activity and Function in Patients With Gynecological Malignancies After Completed Treatment
AU - Grimm, Donata
AU - Hasenburg, Annette
AU - zu Eulenburg, Christine
AU - Steinsiek, Lisa
AU - Mayer, Sebastian
AU - Eltrop, Stephanie
AU - Prieske, Katharina
AU - Trillsch, Fabian
AU - Mahner, Sven
AU - Woelber, Linn
PY - 2015/7
Y1 - 2015/7
N2 - OBJECTIVE: Sexual activity (SA) and sexual function (SF) after completion of treatment are central for quality of life (QoL) in women affected by gynecological cancer (GC). The aim of this study was to analyze the sexual outcome and overall QoL of women after treatment for primary GC compared with a healthy control group (CG).METHODS: In a multicenter cross-sectional study, 77 women aged 28 to 67 years were surveyed at least 12 months after completion of primary therapy for cervical, endometrial, or vulvar cancer [gynecological cancer group (GCG)]. Data were collected through validated questionnaires (Female Sexual Function Index-d, EORTC Quality of Life Questionnaire-C30, and Sexual Activity Questionnaire) and compared to a control of 60 healthy women (CG).RESULTS: In the GCG, 41.3% were sexually active compared to 78.0% in the CG. Twelve women of the CG and 42 women of the GCG indicated the reasons for their sexual inactivity. The most common reason for sexual inactivity in the GCG was "the-presence-of-a-physical-problem" [18/42 (42.9%) vs 2/12 (16.7%) in the CG], whereas in the CG, "because-I-do-not-have-a-partner" was most common [6/12 (50.0%) vs 11/42 (26.2%) in the GCG]. Sexually active patients in the GCG had an SF comparable to the CG. In multivariate analysis of the total cohort (n = 137), relationship status [solid partnership vs living alone; odds ratio (OR), 33.82; 95% confidence interval (CI), 4.83-236.70], smoking (OR, 0.25; 95% CI, 0.06-1.03), and age (OR, 0.87; 95% CI, 0.79-0.94) influenced SA significantly. The probability of SA thereby decreased with increasing age. Quality of life and subjective general health status were not significantly different between the GCG and the CG (EORTC Quality of Life Questionnaire-C30 score 68.25 vs 69.67).CONCLUSIONS: A high number of patients with GC remain sexually inactive after treatment, indicating that women experience persistent functional problems. However, women who regain SA after completed treatment have a good overall SF and vice versa.
AB - OBJECTIVE: Sexual activity (SA) and sexual function (SF) after completion of treatment are central for quality of life (QoL) in women affected by gynecological cancer (GC). The aim of this study was to analyze the sexual outcome and overall QoL of women after treatment for primary GC compared with a healthy control group (CG).METHODS: In a multicenter cross-sectional study, 77 women aged 28 to 67 years were surveyed at least 12 months after completion of primary therapy for cervical, endometrial, or vulvar cancer [gynecological cancer group (GCG)]. Data were collected through validated questionnaires (Female Sexual Function Index-d, EORTC Quality of Life Questionnaire-C30, and Sexual Activity Questionnaire) and compared to a control of 60 healthy women (CG).RESULTS: In the GCG, 41.3% were sexually active compared to 78.0% in the CG. Twelve women of the CG and 42 women of the GCG indicated the reasons for their sexual inactivity. The most common reason for sexual inactivity in the GCG was "the-presence-of-a-physical-problem" [18/42 (42.9%) vs 2/12 (16.7%) in the CG], whereas in the CG, "because-I-do-not-have-a-partner" was most common [6/12 (50.0%) vs 11/42 (26.2%) in the GCG]. Sexually active patients in the GCG had an SF comparable to the CG. In multivariate analysis of the total cohort (n = 137), relationship status [solid partnership vs living alone; odds ratio (OR), 33.82; 95% confidence interval (CI), 4.83-236.70], smoking (OR, 0.25; 95% CI, 0.06-1.03), and age (OR, 0.87; 95% CI, 0.79-0.94) influenced SA significantly. The probability of SA thereby decreased with increasing age. Quality of life and subjective general health status were not significantly different between the GCG and the CG (EORTC Quality of Life Questionnaire-C30 score 68.25 vs 69.67).CONCLUSIONS: A high number of patients with GC remain sexually inactive after treatment, indicating that women experience persistent functional problems. However, women who regain SA after completed treatment have a good overall SF and vice versa.
U2 - 10.1097/IGC.0000000000000468
DO - 10.1097/IGC.0000000000000468
M3 - SCORING: Journal article
C2 - 26098093
VL - 25
SP - 1134
EP - 1141
JO - INT J GYNECOL CANCER
JF - INT J GYNECOL CANCER
SN - 1048-891X
IS - 6
ER -